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University Health Network, Toronto, ON, Canada M5G 1L7Received 19 August 2008; received in revised form 10 November 2008; accepted 13 November 2008Abstract Human pluripotent cells such as human embryonic stem cells (hESC) are a great potential source of cells for
cell-based therapies; however, directing their differentiation into the desired cell types with high purity remains a
challenge. The stem cell microenvironment plays a vital role in directing hESC fate and we have previously shown that
manipulation of colony size in a serum- and cytokine-free environment controls self-renewal and differentiation toward
the extraembryonic endoderm lineage. Here we show that, in the presence of bone morphogenetic protein 2 and activin
A, control of colony size using a microcontact printing technology is able to direct hESC fate to either the mesoderm or
the endoderm lineage. Large, 1200-μm-diameter colonies give rise to mesoderm, while small 200-μm colonies give rise to
definitive endoderm. This study links, for the first time, cellular organization to pluripotent cell differentiation along the
mesoderm and endoderm lineages.
© 2008 Published by Elsevier B.V.Introduction
For pluripotent human cells such as embryonic stem cells
(hESC) to be used as a source for cell-based therapies,
protocols need to be developed that can guide their
differentiation into specific cell types with high purity. In
particular, transplantable tissues derived from the meso-
derm (e.g., hematopoietic cells) and endoderm (e.g.,
insulin-secreting β cells) are of immediate interest for⁎ Corresponding author. Fax: +1 416 978 2666.
E-mail address: peter.zandstra@utoronto.ca (P. Zandstra).
1873-5061/$ – see front matter © 2008 Published by Elsevier B.V.
doi:10.1016/j.scr.2008.11.004treating blood disorders and diabetes. We have previously
shown that controlling hESC colony size using microcontact
printing is able to direct hESC fate in a serum- and cytokine-
free environment in which large colonies show increased
self-renewal and small colonies differentiate into extraem-
bryonic endoderm (Peerani et al., 2007). Moreover, previous
studies have shown that bone morphogenetic proteins (BMP)
and activin/nodal are able to induce primitive streak-like
differentiation of ESC (Ng et al., 2005a; Nostro et al., 2008).
These studies, however, demonstrate that under these
conditions a mixture of mesoderm- and endoderm-fated
cells emerges when, ideally, a pure population is desired for
cell-based therapies (Shiraki et al., 2008; Tada et al., 2005;
Yang et al., 2008).
156 L.H. Lee et al.Here we show that activin A and BMP2 act synergistically
to induce the expression of the primitive streak transcription
factors Brachyury (Bry) and Mix 1 homeobox-like 1 (Mixl1).
However, the expression of mesoderm-specific and endo-
derm-specific genes is also upregulated, indicating the
appearance of both mesoderm- and endoderm-fated cells.
Having shown that colony size is able to regulate hESC
differentiation in a serum- and cytokine-free environment,
we hypothesized that controlling colony size might also be
able to selectively guide these primitive streak-like cells to
either mesoderm or definitive endoderm lineages. In the
presence of activin A and BMP2 we found that smaller
colonies direct hESC differentiation toward definitive endo-
derm and larger colonies lead to mesoderm differentiation.
The functional relevance of controlling colony size and early
mesendoderm differentiation was confirmed through hema-
topoietic and primitive gut differentiation assays, in which it
was found that the larger colonies led to a 10-fold increase in
hematopoietic colony-forming units (CFU), whereas the
smaller colonies gave rise to FoxA2 (forkhead homeobox
A2)-, HNF1β (hepatocyte nuclear factor 1β)-, and HNF4α-
expressing primitive gut tube cells and the larger colonies did
not. These results demonstrate the ability of colony size inFigure 1 BMP2 and activin A interact to elicit the expression of
fluorescence image of Bry expression following 48 h of treatment with
a function of varying BMP2 and activin A concentrations; values
Quantitative gene expression analysis showing upregulated expre
endoderm-associated transcripts; values and error bars represent the
Immunofluorescence image showing Sox17 expression following 48
magnification: 40×. Scale bar, 100 μm. Images of negative control sthe presence of inductive factors to selectively guide hESC
differentiation to either endoderm or mesoderm in a serum-
free environment.
Results
Activin A and BMP2 synergistically induce primitive
streak-like development from hESC
To determine the optimal conditions for primitive streak-like
differentiation of hESC, we treated hESC with varying
concentrations of activin A and BMP2 for 48 h and measured
the frequency of cells expressing Bry, a transcription factor
expressed in the primitive streak of developing mouse
embryos. Using quantitative immunofluorescent microscopy
(see Supplementary Methods) we found that Bry expression
increases with increasing BMP2 and activin A concentrations,
with the greatest frequency of Bry expression (25.6±0.6%)
obtained at 50 ng/ml activin A and BMP2 (Figs. 1a and 1b).
Quantitative gene expression analysis confirms the upregula-
tion of Bry as well as Mixl1 expression. Mixl1 is another
marker of primitive streak development (Fig. 1c). In additionboth mesoderm- and endoderm-associated genes. (a) Immuno-
50 ng/ml BMP2 and activin A. (b) Frequency of Bry expression as
represent the mean of three independent experiments. (c)
ssion of primitive streak markers as well as mesoderm- and
mean and standard error of three independent experiments. (d)
h of treatment with 50 ng/ml BMP2 and activin A. Original
amples can be found in Supplementary Fig. 1.
157Spatial control of differentiationto primitive-streak genes, the expression of mesoderm-
(KDR, Mesp1, Wnt3, and PDGFRa) (Davis et al., 2008;
Kennedy et al., 2007; Rivera-Perez and Magnuson, 2005;
Saga et al., 1996) and endoderm-specific genes (Sox17, GSC,
Cer1) (Izumi et al., 2007; Perea-Gomez et al., 1999) is also
upregulated (Fig. 1c) and is confirmed through immuno-
fluorescence showing protein expression of Sox17 (Fig. 1d).
This demonstrates that both mesoderm and endoderm
precursors arise in the presence of BMP2 and activin A and
that further control of the ESC microenvironment is required
to dissect the two populations.
Manipulating colony size controls mesoderm and
endoderm differentiation of primitive streak-like cells
We previously showed that manipulating hESC colony size in
the absence of exogenous inductive signals using micro-
contact printing can control hESC self-renewal and differ-
entiation (Peerani et al., 2007). Here we used a similar
technique to manipulate hESC colony size in the presence of
BMP2 and activin A. hESC were dissociated into single cellsFigure 2 Control of colony size regulates mesoderm and en
micropatterned hESC colonies ((i) 200, (ii) 400, (iii) 800, and (iv) 1
of mesoderm- and endoderm-associated transcripts; values and error
experiments. (c) Flow cytometry analysis of Bry, KDR, Sox17, an
Representative histograms are shown and numerical values represe
experiments. Original magnification: 4×. Scale bar, 500 μm. ⁎Significand seeded onto islands of Matrigel with tightly controlled
geometry to form colonies of defined shape and size. We
examined colonies 200, 400, 800, and 1200 μm in diameter
(Fig. 2a) and found that in the presence of BMP2 and activin A
expression of endoderm-associated genes, Sox17, GSC, and
Cer1, increases with decreasing colony size. Conversely,
the expression of Bry and KDR is greatest in larger colony
sizes and, together with low expression of endoderm
markers, indicates mesoderm differentiation (Gadue et al.,
2006; Nostro et al., 2008) in large colonies (Fig. 2b). Gene
expression is further confirmed through protein level
analysis using flow cytometry (Supplementary Methods),
showing a 1.3- and 1.8-fold increases in Bry and KDR, res-
pectively, as well as a 2.5-fold decrease in Sox17 expression
frequency in large 1200-μm colonies compared to small 200-
μm colonies (Fig. 2c). Surface expression of the mesoderm-
associated protein PDGFRa (platelet-derived growth factor
receptor-α, also known as CD140a) (Davis et al., 2008) was
also analyzed by flow cytometry; however, greater expres-
sion was found in the small 200-μm colonies, contrary to the
observed trend in Bry and KDR expression (Fig. 2c). Althoughdoderm differentiation of hESC. (a) Bright-field images of
200 μm in diameter). (b) Quantitative gene expression analysis
bars represent the mean and standard error of nine independent
d PDGFRa protein expression in 200- and 1200-μm colonies.
nt the mean and standard error of at least three independent
ance (Pb0.05) of 1200- compared to 200-μm colonies.
158 L.H. Lee et al.the reason for this apparent discrepancy is not clear,
together our data suggest that, while mesoderm differentia-
tion is favored in large colonies, endoderm differentiation is
favored in small colonies.
Larger, mesoderm-enriched colonies generate
greater numbers of hematopoietic progenitors
We employed a serum-free hematopoietic differentiation
assay to determine if the larger, mesoderm-enriched colonies
possess greater capacity for hematopoietic differentiation.
We used forced-aggregation embryoid body (EB) formation
(Ng et al., 2005b; Ungrin et al., 2008) to initiate hemato-
poietic differentiation because it allows us to uniformly
control the differentiation conditions under which the only
parameter that is varied is the colony size during the initial
48-h primitive streak-like induction step. Following 9 days of
suspension culture in serum-free medium supplemented with
hemogenic cytokines, embryoid bodies derived from 200- and
1200-μm colonies were assessed for hematopoietic differ-
entiation. Flow-cytometry analysis of hematoendothelial
surface markers showed a 2.5-fold increase (P=0.01) in theFigure 3 Larger, mesoderm-enriched colonies show greater hema
of EB derived from 200- and 1200-μm colonies following 9 days o
mean±standard error, of five independent experiments, of the perce
CD34, CD31, and KDR. (b) Hematopoietic colony-forming frequency of
represent mean and standard error of three independent experiment
magnification: 4× and 10×. Scale bar, 200 μm. (d) Morphological ana
using Wright–Giemsa staining showing monocytes and macrophage
compared to 200-μm colonies.frequency of cells coexpressing CD34, CD31, and KDR in
embryoid bodies derived from larger 1200-μm colonies
compared to the smaller 200-μmcolonies (Fig. 3a). Moreover,
colony-forming assays reveal a 10-fold increase (P=0.04) in
the frequencies of hematopoietic CFU found in embryoid
bodies formed from larger colonies compared to smaller
colonies (Figs. 3b and 3c). Morphological analysis of EB-
derived hematopoietic colonies using Wright–Giemsa stain-
ing confirms the presence of mixed myeloid lineage cells in
selected colonies (Fig. 3d).
Smaller, endoderm-enriched colonies lead to greater
primitive gut endoderm differentiation
To confirm that the larger colonies are deficient in endoderm
precursors, while the smaller colonies are enriched, we
employed a previously established endoderm differentiation
protocol (D'Amour et al., 2006; Kroon et al., 2008). Following
2 days of treatment in activin A, cultures originating from
200-μm colonies express CXCR4 (chemokine (C-X-C motif)
receptor 4), a marker of definitive endoderm (D'Amour et al.,
2006; Yasunaga et al., 2005), at significantly greatertopoietic differentiation potential. (a) Flow-cytometry analysis
f suspension culture in hemogenic cytokines; values represent
ntage coexpressing all three hematoendothelial surface markers,
EB derived from 200- and 1200-μmcolonies; values and error bars
s. (c) Representative images of hematopoietic colonies. Original
lysis of cytospin preparations of EB-derived hematopoietic cells
s. Original magnification: 40×. ⁎Significance (Pb0.05) of 1200-
Figure 4 Smaller, endoderm-enriched colonies show greater primitive gut endoderm-forming potential. (a) Flow-cytometry analysis
of CXCR4 expression following reseeding of micropatterned colonies and 2 days of culture in activin A. Representative histograms are
shown and values represent mean and standard error of four independent experiments. (b) Immunofluorescence images of HNF1β,
FoxA2, and HNF4α expression after further differentiation with FGF7 followed by Noggin, cyclopamine, and retinoic acid. (c)
Quantitative gene expression analysis following endoderm differentiation assay. RNA isolated from hESC is shown as a negative
control. Original magnification: 40× . Scale bar, 100 μm. Significance (⁎Pb0.05 and ⁎⁎Pb0.01) of 1200- compared to 200-μm colonies is
indicated.
159Spatial control of differentiationfrequencies compared to the 1200-μm colonies as measured
by flow cytometry (Fig. 4a). Moreover, after treatment with
FGF7 followed by Noggin, cyclopamine, and retinoic acid,
cultures originating from the 200-μm colonies express
markers of primitive gut endoderm, including HNF1β
(Coffinier et al., 1999), FoxA2 (Sasaki and Hogan, 1993),
and HNF4α (Duncan et al., 1994), while cultures originating
from the 1200-μm colony cultures do not (Fig. 4b). Protein
expression was further confirmed through quantitative gene
expression analysis showing greater expression of Foxa2,
HNF1β, and HNF4α in cultures originating from the smaller
200-μm colonies compared to the larger 1200-μm colonies
(Fig. 4c).Discussion
The emergence of a primitive streak-like phenotype has been
described from mouse and human ESC (Davis et al., 2008;
Gadue et al., 2006; Nostro et al., 2008; Yang et al., 2008);
however, the regulation of the further commitment of these
cells remains challenging. Although fluorescent reporter cell
lines combined with cell sorting are powerful tools that have
been used to isolate target cell types from mixed cell
populations (Davis et al., 2008; Yang et al., 2008), better
technologies for the generation of specific mesoderm- and
endoderm-derived cells are needed. Here we show that by
precisely controlling colony size we are able to manipulatehESC fate to either mesoderm or endoderm lineages.
Interestingly, this size-dependent control of cell fate occurs
even in the presence of high concentrations of inductive
factors (activin A and BMP2), suggesting an important role for
endogenous signaling in pluripotent cell specification.
We have used the a blood progenitor cell assay (CFC) to
determine if the apparent changes in mesoderm versus
endoderm differentiation result in differences in the output
of derivative tissues. We demonstrate that larger mesoderm-
enriched colonies give rise to greater frequencies of CFC,
while smaller endoderm-enriched colonies more effectively
differentiate into primitive gut precursors. Although the
hematopoietic CFC frequency reported here is lower than in
previous reports (Chadwick et al., 2003; Ng et al., 2005a),
this is probably due to suboptimal conditions for generating
hematopoietic progenitors from mesoderm precursors under
defined serum-free conditions. It is also likely that other
mesoderm lineages, such as cardiac or somitic mesoderm,
are being generated. Moreover, the markers used here to
delineate mesoderm from endoderm lineages (Bry, KDR, GSC,
Sox17, and Cer1) are not strictly confined to a particular
germ layer, as reports have shown their expression in
mesoderm, endoderm, and undifferentiated hESC (Kubo et
al., 2004; Tada et al., 2005; Yang et al., 2008). Additionally,
the observed trend in PDGFRa expression is seemingly
contrary to what might be anticipated from previous reports
demonstrating that PDGFRa marks mesoderm and hemato-
poietic precursors from hESC (Davis et al., 2008). However,
160 L.H. Lee et al.the report by Davis and colleagues found that the PDGFRa-
negative population is still able to give rise to a significant
PDGFRa-expressing population following further differentia-
tion and that a significant number of hematopoietic colonies
do arise from the initially PDGFRa-negative population. This
suggests that PDGFRa expression is not an accurate predictor
of hESC lineage commitment at the early time points
examined here. In the experiments performed here, PDGFRa
expression was lower in the early mesoderm-enriched
population.
Although only transforming growth factor β (TGFβ)
pathway activators were used to induce endoderm and
mesoderm precursors, it is possible that other signaling
pathways are also responsible for the colony-size-mediated
effect described here. Wnt signaling is required for the in
vivo primitive streak development of mouse embryos (Liu
et al., 1999) and has been implicated in early lineage
specification of hESC (Sumi et al., 2008); however, in the
presence of activin A and BMP2 the addition of soluble Wnt
ligand (Wnt3a, 50 ng/ml) did not increase Bry expression
(data not shown). This is explained by the upregulation of
Wnt3 expression (Fig. 1c), which is sufficient to allow
primitive streak-like differentiation. Moreover, it has also
been shown that RhoA activation mediated by cell shape and
cytoskeletal tension regulates adipocyte and osteogenic
differentiation of human mesenchymal stem cells (McBeath
et al., 2004), but a detailed investigation of Rho signaling
in hESC has yet to be conducted. Additionally, PI3-kinase
signaling has been implicated in definitive endoderm
differentiation of hESC (McLean et al., 2007). Further
investigation is required to elucidate the role of these
signaling pathways on the colony-size-mediated effect
described here.
By controlling the colony size, we are able to engineer the
response of hESC in the presence of exogenous cytokines.
Combining this technology with strategies to specify meso-
derm and endoderm cells using exogenous factors (Chadwick
et al., 2003; Nostro et al., 2008; Yang et al., 2008; Zhang et
al., 2008) may reduced heterogeneity in cell responses and
increase target cell yields.
Materials and methods
Cell lines and cell culture
All experiments described were performed using the hESC
lines H9, I6, and HES2. hESC were maintained on irradiated
mouse embryonic feeder cells (mEF) in serum-free medium
consisting of knockout (KO) Dulbecco's modified Eagle's
medium (DMEM; Invitrogen) and 20% KO serum replacement
(Invitrogen) supplemented with 4 ng/ml recombinant human
(rh) basic fibroblast growth factor (bFGF; PeproTech).
hESC differentiation
Prior to differentiation to remove mEF, hESC were passaged
as clumps onto Matrigel (BD Biosciences)-coated substrates
or micropatterned Matrigel substrates in defined serum-free
medium consisting of X-Vivo10 medium (Cambrex) supple-
mented with 2 mM GlutaMAX (Invitrogen), 1×nonessential
amino acids (NEAA; Invitrogen), 0.1 μM β-mercaptoethanol(BME; Sigma), 40 ng/ml bFGF (PeproTech), 0.1 ng/ml rh-
TGFβ1 (R&D Systems), and 5 ng/ml rh-activin A (R&D
Systems). Micropatterned Matrigel substrates and hESC
colonies were generated as previously described (Peerani
et al., 2007). Following overnight seeding of hESC, medium
was replaced with X-Vivo10 medium supplemented with
2 mM GlutaMAX, 1× NEAA, 0.1 μM BME, and cytokines as
indicated. Rh-BMP2 (R&D Systems) and rh-activin A (R&D
Systems) were used at 50 ng/ml unless otherwise indicated.
Formation of forced aggregation embryoid bodies
and hematopoietic assay
EB were formed through forced aggregation as previously
described (Ng et al., 2005b; Ungrin et al., 2008). Briefly,
following 48 h of treatment with BMP2 and activin A,
micropatterned colonies of 200 or 1200 μm diameter were
dissociated into single cells using TrypLE Express and then
resuspended in serum-free hemogenic medium (XV-hem)
supplemented with 10 μM Y-27632 Rho kinase (ROCK)
inhibitor to enhance survival of hESC (Watanabe et al.,
2007). XV-hem is composed of X-Vivo10 medium supplemen-
ted with 2 mM GlutaMAX, 1×NEAA, 0.1 μM BME, rh-stem cell
factor (50 ng/ml; R&D Systems), rh-Flt-3 ligand (150 ng/ml;
R&D Systems), and rh-vascular endothelial growth factor165
(10 ng/ml; R&D Systems). The single-cell suspension was
placed onto a microtextured surface containing pyramidal
wells of 800 μm in width (Ungrin et al., 2008) and centrifuged
at 400 g for 3 min to obtain pellets of 5000 cells per
microwell. Prior to EB formation, microtextured surfaces
were passivated using Pluronic F-127 for 1 h to facilitate EB
removal. Following overnight culture, the forced-aggregate
EB were removed from the microwells and rinsed with PBS to
remove the ROCK inhibitor. EB were subsequently cultured in
suspension in XV-hem medium for a further 8 days. For
colony-forming assay, embryoid bodies were dissociated into
single cells using TrypLE Express and resuspended in
MethoCult GF+ semisolid medium (H4435; Stem Cell Tech-
nologies) at a density of 50,000 cells/ml. For cytospin
preparation, the hematopoietic colonies were extracted
from MethoCult cultures and Wright–Giemsa staining of
cytospin preparations was carried out to assess nuclear and
cytoplasmic morphology of the cells.
Endoderm differentiation assay
The endoderm differentiation protocol employed here was
originally described by D'Amour et al. (2006). Following 48 h of
treatment with BMP2 and activin A, micropatterned colonies
were reseeded onto Matrigel-coated substrates in X-Vivo10
medium supplemented with 100 ng/ml activin A. Following 2
days of culture, the medium was replaced with RPMI medium
1640 (Gibco) supplementedwith 2% fetal bovine serum (Gibco),
2 mM GlutaMAX, 50 u/ml penicillin/streptomycin (Invitrogen),
and 50 ng/ml fibroblast growth factor 7 (or keratinocytes
growth factor; R&D Systems). Following 3more days of culture,
the medium was replaced with DMEM (Invitrogen) supplemen-
ted with 1% B27 supplement (Gibco), 2 mM GlutaMAX, 50 u/ml
penicillin/streptomycin, 50 ng/ml Noggin (R&D Systems),
250 nM cyclopamine (a kind gift from Dr. Derek van der Kooy,
University of Toronto), and 2 μM retinoic acid.
161Spatial control of differentiationQuantitative gene expression analysis
Total RNA was extracted from cells using TRIzol reagent
(Invitrogen) and purified using the RNeasy mini RNA isolation
kit (Qiagen). cDNA was synthesized from purified RNA using
the SuperScript III reverse transcriptase kit. Real-time
quantification of transcripts using polymerase chain reaction
was performed using Power SYBR Green PCR Master Mix
(Applied Biosystems) and a 7900HT Fast real-time PCR
system (Applied Biosystems). Both β-actin and GusB were
used as endogenous controls and yielded very similar results,
but the transcript levels presented here were calculated as
2Δ(ΔCt) normalized to β-actin. A list of primer sequences can
be found in Supplementary Table 1.
Statistical analysis
Statistics were computed based on paired Student t tests.
Error bars represent the standard error of the mean of at
least three replicates using H9, I6, and HES2 hESC lines.
Single and double asterisks indicate statistical significance of
Pb0.05 and Pb0.01, respectively.
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